SOHM Inc (PK) (SHMN) Quote

The easiest way to regain some credibility is to find another CEO, this one has worn out his welcome as far as I'm concerned.

A share buyback would be great except they don't have the money.

Now if they start selling ABBIE Kits/ License deals the money should start coming in....

Agreed. A buyback is needed. I have been pushing for this. They need to regain credibility. Show to investors they believe in the work they have been putting in for over a year now. You can’t buy a home in California for the market cap of this company. They should be buying at these absurdly depressed levels.

keep low bids in, the weekly walk down has commenced, ground hog week....

I tend to agree with that JD, but no one knows where ABBIE is headed. The OS for instance could be lowered with some serious share buyback, yeah, someone had to say it, might as well be me. Initial sales, if good, could pay for that easily.

SHMN shares are not being introduced to the right people by the co. Are they trying ?

With ABBIE having so much potential it boggles my mind that anyone that follows genome editing technology would not want to invest.

Especially at triple 7.....

this stock will go through the roof. We are talking into the dollar range and higher

I applaud your enthusiasm, but it's probably wise to temper your expectations.

SHMN currently has 1.998 billion shares outstanding; there's no way (barring a short squeeze) that this company justifies a $2BB market cap.

I expect to see a penny plus if the annual/Q1 reports show revenue, and hope for a nickel. I dream of a dime, but even that's pushing the limits of feasibility based solely on market cap implications (currently looking at the chart of a $300MM/yr Nasdaq company with a market cap of $350MM).

no problem, this thing ever goes back to copper and I'm buying a case of each flavor.....

I need a Gummie...

Don't forget to bring enough to share with the rest of us!

yep, James Bond would surely look better....

I need a Gummie...

Heck, getting rid of one of those decimal trailing zeroes would cheer me up!

I think it's going to take a combination of news and earnings to make this move. This company has a lengthy history of making splashy announcements with little to no follow-through. While a PR used to move the needle, they're all but ignored these days.

I think/hope that this era has passed, but until some of their more recent announcements (including the EOY video shared on this board) result in tangible revenue as reflected in a quarterly/annual report, potential investors have no reason to believe what they're saying.

March 31 (2024 annual) and/or May 15 (2025 Q1) will be instructive as to whether they really have turned the corner; I don't anticipate any actual movement in PPS until those reports come out.

right now above sea level would be nice !

lol....

To infinity and beyond!

Unfortunately, until there is some BIG news posted across multiple platforms and channels this stock will stay dormant hopefully with everything in play they can release a solid PR to potential whale investors ready to jump on board and send this stock into penny land otherwise we will be stuck in the sub basement. 

Nice graph on FDA Approved Cell and Gene therapies:

https://www.linkedin.com/posts/joanna-sadowska-phd_approval-fda-genetherapy-activity-7284554822131798017-e1to?utm_source=share&utm_medium=member_android


----

"We will be releasing additional information regarding our position in Europe and Korea in the near future."

3:00 minute mark: https://x.com/sohminc/status/1874344120971587899

Top 10 Pharmaceutical Companies in Europe in 2022 by Market Capitalization

https://www.globaldata.com/companies/top-companies-by-sector/healthcare/europe-companies-by-market-cap/#:~:text=Top%2010%20Pharmaceutical%20Companies%20in%20Europe%20in%202022%20by%20Market%20Capitalization,-Share&text=Showing%2010%20out%20of%2023,of%20Mar%2031%2C%202023).

Top 10 Pharma Companies in South Korea by Market Cap

https://www.globaldata.com/companies/top-companies-by-sector/healthcare/south-korea-companies-by-market-cap/#:~:text=Celltrion%20Inc%20is%20the%20leading,It%20employs%201%2C067%20people.

Good morning, checking with this stock again to see if I can recover any money. Tried erasing my previous comments but the system does not allow to delete posts.

Market closed today, but keep low bids in place until the co makes a worthwhile announcement.

I have too. The video says a mouthful. I was going to ask someone to create a transcript from it, and would like a PR of the contents even better.

Aguillar said things not yet fully elaborated. Like the ongoing collaborations with Stanford, Coastar, and Universal Sequencing.

11 patents applications/approvals...up from 4 the beginning of 2023.

He was also noticeably animated when he mentioned they have one of "the best patent IP firms, Knobbe Martens." (Something only mentioned before in filings.)

(More could also be mentioned about his confirmation of continuing Brainwise orders, and the development of IProlec, though of lesser concern to me than ABBIE)

Also, Manufactuting license in California for Carlsbad, and Wholesale license in New Jersey.
(Significance yet unknown as related to Levitiracetam)

So much to mention...thus a transcript of the video would be nice.

Passing mention...San Diego is still "under consideration" pending manufacturing ok from the city of San Diego.

_______________

As you can see, I've been thinking about the video too, all the above is off the top of my head, as I've watched the video several times like you.

Thanks for your post on the mentioned 3 possibilities. We are so overdue for a game changing PR, imo. Respects SLC-JD.

I've been thinking a lot about this video over the last few days...

There are 3 main reasons to pursue a robust patent portfolio:

1) 'offensive' - The company has created or acquired a novel invention, wishes to monetize it through direct sales or licensing, and wants to make sure that its competitors cannot utilize it (this use case also applies to patent trolls)

2) 'defensive' - The company has created or acquired a novel invention, wishes to monetize it through direct sales or licensing, and wants to make sure that its competitors cannot deprive them of the ability to do so.

3) 'blue sky' - The company has created or acquired a novel invention, and while it may not be positioned to monetize it fully, acknowledges that it is a thing of value which may be desirable to others and moreover, may make the company a more desirable acquisition target.

I imagine the coming months will help to clarify which of these positions is being undertaken by SHMN, but my gut keeps telling me that we're probably looking at number 3.

This company is so undervalued all is going to take is for the pieces of the puzzle to finally come together after years and this stock will go through the roof. We are talking into the dollar range and higher I have held onto the stock for well over five years I bought in onceand I've been sitting and waiting in the end is coming soon. 

Hope everyone had a great holiday season. 2025 is when SHMN said ABBIE was going to take off. Let's see what they do.

Aguilar has now confirmed in this new video, that Sohm is collaborating with "Universal Sequencing." (This is the Company that Kawamura works part time for.)

See my linked back post.

SOHM 2025 Momentum and 2024 Recap!

https://twitter.com/sohminc/status/1874344120971587899?t=rWIfnpO9V44NiQnWIW266w&s=19

Walmart Marketplace: "We are glad to share that the company has received approval from Walmart Marketplace to sell our products on its platform. In the next few days as we progress, we will start putting our products on it. This development is another milestone for the company and we are very excited with the development."

https://x.com/sohminc/status/1871252518602485892

I could have sworn I already said that.

Good luck and Happy Festivus to you.

If so, they'd have to wait 30 days to avoid the wash sale rule.

https://www.linkedin.com/posts/joanna-sadowska-phd_pharma-biotech-cancer-activity-7276219880725446657-Rj2l?utm_source=share&utm_medium=member_android

I'm hoping that it is mostly tax-loss selling. The logic being that you can get them back at a tad more 30 days hence. I guess we'll see.

Big bid at .0007s, is that the bottom? Some news about actual ABBIE kit sales would go a long way here.

Well, at least we have something to hope for in this one which is rare in penny land!

After 6+ years it gets easier LOL

if Tom Petty said it HAS to be true....lol...

it was very informative, love this..

how it ABBIE we be an evolving product.

The waiting....is the hardest part!

Just something he sent me that he posted on LinkedIn yesterday.

Gives a little insight to what his plan is with Abbie going forward. and how it ABBIE we be an evolving product.not a stagnant on time sale item.

I didn't hear him mention any sales so far, did I miss something ?

with the annual due 3/31 and the quarterly due 5/15 that's a 6 week window that actual shareholders would have to wait.

waiting is what we do best......

TWEET

SOHM, Inc.
@sohminc
·
18h
Dr. David Aguilar, COO, briefly explains our ABBIE technology and how it can benefit various industries in the near future.

$SHMN

#CRISPR #CAS9 #ABBIE #SOHMINC #Biotech #Geneediting

https://x.com/i/status/1868754648909398070

Valid question, and it will go a long way toward firming up the company's credibility with regard to projections for future activity. The historical issue has been a failure to announce a correction when it became clear that their projections were inaccurate. I hope that the ensuing silence is not a continuation of this precedent.

If there is *any* revenue to speak of, I feel like they are validated. However, if the EOY report is yet another 'concept of a plan to generate revenue in the future' situation, I fear that potential investors will turn their collective backs once again.

I'm not predicting that shit will hit the fan, nor am I slamming the company. I'm hoping that the relatively rosy updates are accurate, and will be reflected in their annual. I'm hoping that the past record of going silent when announced plans don't come to fruition is indeed, a remnant of the past. And most of all, I'm hoping that they manage to generate enough revenue of ABBIE to stir some interest in the market and create some shareholder value (and liquidity).

Will SOHM sell any ABBIE kits before the end of the month or are we going to have to wait until May to see if they sell any in Q1 2025?

As an actual shareholder I'm not at all interested on why the SD plans haven't materialized yet, it's pretty obvious to me that the Carlsbad facility was the better move at the time. Does this bother the non shareholders ?

SOHM Announces New CDMO GMP Manufacturing Facility in Carlsbad, California
November 21, 2023 09:30 ET

https://www.globenewswire.com/news-release/2023/11/21/2784138/0/en/SOHM-Announces-New-CDMO-GMP-Manufacturing-Facility-in-Carlsbad-California.html

Soooo about that San Diego facility..... 2 years ago and still nothing.

https://x.com/sohminc/status/1593330828913741824

Agreed, they seem to be putting the pieces in place but it's taking longer than expected to see the results in revenues. Once the revenues flow, the investors will show.

All the best,

Knife

I remain hopeful too JD, glass half full and all that.....

It would be very hard to think they would hire all these new people if they weren't sure of upcoming sales...

so we wait..

Semi-irrational heights. Great phrase. I'm hoping so too.

the only thing that will move this pps is an announcement of actual sales

Truer words have never been spoken.

That said, I remain hopeful that if/when actual sales numbers finally break the logjam (which, to be fair, was created by the company's history of baseless and unrealized revenue projections), there will be enough upward pressure to drive PPS to at least semi-irrational heights.